Calculates the Clinical Index of Stable Febrile Neutropenia in selected adults with solid tumours. This guide explains the intended use, interpretation, limitations and safe clinical application of CISNE Score.
Clinical Role and Decision Question
CISNE Score is presented in MediCalc as a clinical score within Oncology. Calculates the Clinical Index of Stable Febrile Neutropenia in selected adults with solid tumours. Its value is greatest when it is used to answer a clearly defined clinical question, with the result interpreted alongside the history, examination, observations and other investigations rather than in isolation.
CISNE Score is an item-based clinical score. The total only has meaning when each component is assessed according to the original definitions, missing or untestable items are handled as specified by the source method, and the final band is interpreted in the population for which the score was validated.
In practice, the useful question is not simply “what number does CISNE Score produce?” but “does this tool apply to this patient, at this time, for this decision?” A technically correct calculation can still be clinically misleading if it is used outside the population, setting or purpose for which the underlying method was developed or validated.
In haematology and oncology, disease subtype, treatment phase, recent therapy and rapidly changing laboratory values may influence risk. Interpret the result in the context of the current treatment pathway and specialist guidance.
Patient Selection, Timing and Applicability
Before using CISNE Score, confirm that the patient and clinical episode match the intended scope of the tool. Consider age group, care setting, disease state, treatment already given, timing of measurements and any exclusion criteria described by the original publication or current specialty guidance. If those conditions are uncertain, document the uncertainty rather than assuming that the result has the same meaning in every context.
Timing matters because many clinical variables change rapidly. A score assembled from observations taken at different stages of an illness may not represent one coherent physiological state. Where possible, use contemporaneous values and make the time point explicit, particularly when the result may influence escalation, referral, monitoring intensity or a discussion of prognosis.
The same principle applies after an intervention. Measurements obtained before fluids, oxygen, analgesia, ventilation, medication or another material change in treatment may not be interchangeable with values obtained afterwards. Recalculate when the clinical question changes or when key source variables have materially changed.
Registered use context: Use only in the validated patient population and clinical setting. Confirm that all required inputs are current and accurately measured. Apply the result alongside the full clinical assessment and local guidance.
CISNE Score depends on the quality of the data entered. The following inputs are taken from the registered MediCalc implementation. Each should be verified before the result is used clinically; a plausible-looking value is not a substitute for confirming how and when it was obtained.
- Stress Hyperglycaemia: Required input for the registered calculation. Confirm the source, timing and units or response definition before accepting the entry.
- ECOG Performance Status ≥2: Required input for the registered calculation. Confirm the source, timing and units or response definition before accepting the entry.
- Chronic Obstructive Pulmonary Disease: Required input for the registered calculation. Confirm the source, timing and units or response definition before accepting the entry.
- Chronic Cardiovascular Disease: Required input for the registered calculation. Confirm the source, timing and units or response definition before accepting the entry.
- Oral Mucositis Grade ≥2: Required input for the registered calculation. Confirm the source, timing and units or response definition before accepting the entry.
- Monocytes <200/µL: Required input for the registered calculation. Confirm the source, timing and units or response definition before accepting the entry.
If a required input is missing, ambiguous or measured under materially different physiological conditions, consider whether the calculation should be deferred. Avoid substituting a related variable unless the source method specifically allows it. For categorical inputs, use the option that best matches the verified assessment rather than the option that produces the expected or preferred result.
Unit errors are a common source of apparently credible but incorrect outputs. Check unit labels, decimal placement, conversion factors and whether the source laboratory or monitor reports in the same convention expected by the calculator. When values are copied from another system, verify the original result rather than relying on a transcribed secondary source.
Calculation and Scoring Integrity
MediCalc is intended to reproduce the registered calculation or scoring logic for CISNE Score, but mathematical reproducibility is only one part of safe use. The definitions attached to each variable, the order in which observations are collected and the handling of unavailable data can all affect whether the final result corresponds to the method described in the evidence base.
For equation-based tools, avoid unnecessary rounding of intermediate values and confirm that measured variables use the expected units. For item-based scores, complete each item according to the original definitions and retain the individual responses when they are clinically meaningful. For decision-support rules, do not skip a branch or criterion simply because another feature appears more important.
If the result is unexpected, first re-check the inputs and definitions rather than assuming the tool is wrong or the patient is atypical. A second calculation using independently verified source data is often a useful quality check when the output could materially influence care.
Interpreting the Result in Clinical Context
The output from CISNE Score should be interpreted as decision-support information, not as a diagnosis or treatment instruction by itself. Consider whether the result agrees with the patient’s trajectory, examination findings, available investigations and the clinical question that prompted use of the tool.
Where the underlying method defines thresholds, risk bands or action categories, apply those boundaries exactly as published and according to current guidance. Do not create new intermediate categories or extrapolate beyond the range for which the instrument was evaluated without an explicit clinical rationale.
Results close to a decision boundary deserve particular care. Biological variability, measurement uncertainty, timing and differences between local protocols can change the practical significance of a small numerical difference. When a result lies near a threshold, reviewing the raw inputs and the whole clinical picture is usually more informative than treating the boundary as absolute.
Registered interpretation note: Interpret the result according to the category and explanation shown by the calculator. Consider whether exclusions, confounders or urgent clinical features limit application. Do not use a single score or calculated value as the sole basis for diagnosis, disposition or treatment.
Discordant, Borderline or Unexpected Results
A result that conflicts with clinical judgement should trigger review, not automatic acceptance or automatic dismissal. Re-check patient identity, source observations, units, timing, data entry and eligibility for the tool. Consider whether treatment or deterioration between measurements has made the inputs internally inconsistent.
If the calculation remains valid but the result still appears discordant, give appropriate weight to direct clinical assessment and seek senior or specialist input when the decision is important. Clinical tools simplify selected aspects of a patient’s state; they cannot represent every comorbidity, competing diagnosis, treatment effect or contextual factor that may influence an individual case.
Documenting discordance can be valuable. It records that the tool was considered, identifies why the result was not followed mechanically and creates a clearer audit trail for subsequent clinicians reviewing the same episode of care.
Limitations, Bias and External Validity
Clinical calculators inherit the strengths and weaknesses of the studies from which they were derived and validated. Performance can vary with disease prevalence, case mix, referral patterns, ethnicity, age, comorbidity, treatment era and clinical setting. A result may therefore be less reliable when the patient differs substantially from the populations represented in the evidence base.
Missing data, inter-observer variation and measurement error can introduce additional bias. Some variables are highly reproducible laboratory measurements; others depend on clinical judgement or patient participation. The apparent precision of a numerical result should not be mistaken for certainty about the underlying patient state.
Consider calibration as well as discrimination when reviewing published performance. A tool can separate higher- and lower-risk groups reasonably well while systematically over- or under-estimating absolute risk in a different population. Local validation, specialty guidance and current clinical standards are therefore important when the output is used to support consequential decisions.
Registered limitations: Performance may differ outside the original validation population. Missing, estimated or rapidly changing inputs can reduce reliability. The tool does not replace clinical judgement, local pathways or specialist assessment.
Safety, Escalation and Professional Judgement
CISNE Score must not delay urgent assessment or treatment when these are indicated independently of the calculated result. Red flags, physiological instability, time-critical diagnoses and safeguarding concerns should be acted on according to clinical need even if a score or calculated value appears reassuring.
Use current local, national and specialty guidance when translating a result into investigation, monitoring, referral or treatment decisions. The calculator can support a pathway, but it does not replace the pathway itself. Where guidance has changed since the original derivation study, current recommendations take precedence over historical practice.
When the consequences of error are substantial, consider an independent check of the source data and result. This is particularly useful when calculations are used during handover, transfer, escalation discussions, dose-independent treatment decisions or communication of prognosis.
Reassessment, Trending and Change Over Time
A single result is a snapshot. If the patient’s condition is changing, repeating an appropriate tool with comparable measurements can provide useful context, but only when the method is suitable for serial use. The clinical meaning of a change depends on what changed in the inputs, when the measurements were taken and whether treatment altered the underlying physiology.
Do not compare serial results as though they were equivalent if they were calculated from different measurement techniques, units, time points or assessment conditions. When trends are used, retain the individual source values so that an apparent change in the total can be traced back to the variable or item responsible.
Reassessment is also an opportunity to reconsider whether the tool remains the right one for the clinical question. As diagnosis becomes clearer or the care setting changes, direct disease-specific assessment or another validated instrument may become more appropriate.
Documentation, Handover and Audit
When CISNE Score contributes to a clinical decision, record the result together with the relevant source inputs, assessment time and clinical context. This allows another clinician to understand how the value was obtained and whether it still applies later in the patient journey.
Where individual score components or categorical responses carry clinical meaning, document them as well as the total. Recording only the final number can conceal the feature that actually drove the result and can make later review difficult.
For governance and audit, distinguish between the calculator output and the final professional decision. Recording why a result was followed, modified or set aside helps demonstrate appropriate use of decision support and makes multidisciplinary review more informative.
Evidence, Validation and Guideline Alignment
The clinical meaning of CISNE Score ultimately comes from its source literature and subsequent validation, not from the calculator interface. Consult the cited primary or supporting references when exact derivation methods, eligibility criteria, outcome definitions, coefficients, thresholds or validation characteristics are required.
Evidence should be revisited periodically. A calculation can remain mathematically correct while the recommended indications for using it, the preferred comparator, or the action that follows a result changes. Current guidelines, local policy and specialty consensus should therefore be checked when the tool informs active patient care.
Where multiple versions of a score or equation exist, confirm that the version implemented by the calculator matches the version cited by the guideline or publication being followed. Small changes in coefficients, variable definitions or outcome windows can create clinically meaningful differences between superficially similar tools.
Reference trail registered for this tool: Carmona-Bayonas A et al. J Clin Oncol. 2015;33:465–471.
Practical Pre-Use Checklist
- Confirm that the tool addresses the clinical question you are trying to answer.
- Confirm that the patient and setting fit the intended population and exclusions.
- Verify every source value, response definition, unit and time point.
- Review red flags and urgent findings independently of the final calculated result.
- Interpret thresholds or categories using the source method and current guidance.
- Document the inputs, output, timing and how the result influenced clinical reasoning.
- Reassess when the patient changes or when new clinically important information becomes available.
